(19)
(11) EP 4 577 195 A1

(12)

(43) Date of publication:
02.07.2025 Bulletin 2025/27

(21) Application number: 23768011.1

(22) Date of filing: 23.08.2023
(51) International Patent Classification (IPC): 
A61K 9/50(2006.01)
A61P 25/00(2006.01)
A61K 31/403(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/5073; A61K 31/403; A61P 25/00
(86) International application number:
PCT/JP2023/030255
(87) International publication number:
WO 2024/043260 (29.02.2024 Gazette 2024/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 24.08.2022 JP 2022133266

(71) Applicant: Otsuka Pharmaceutical Co., Ltd.
Tokyo 101-8535 (JP)

(72) Inventor:
  • HASEGAWA, Masahiro
    Osaka-shi, Osaka 540-0021 (JP)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) PHARMACEUTICAL COMPOSITION COMPRISING CENTANAFADINE